Financial statements 4Cell Therapies

Balance sheet of 4Cell Therapies

Company age:
Age:
8 y. 3 m. 28 d.
Share capital:
Share capital:
1 101 950 PLN
Profit and loss statement Balance Cash flow Profitability

Balance sheet data of 4CELL THERAPIES

Year
2017
2018
2019
2020
2021
2022
Total assets 1 253 770,61 1 001 588,12 3 008 054,55 9 069 456,00 5 460 835,71 3 514 350,68
A. Fixed assets 746 357,00 533 618,85 224 661,98 1 558 481,92 1 640 403,34 2 661 576,57
B. Current assets 507 413,61 467 969,27 2 783 392,57 7 510 974,08 3 820 432,37 852 774,11
C. Share capital contributions (basic funds) 0,00 0,00 0,00 0,00 0,00 0,00
D. Own shares (stocks) 0,00 0,00 0,00 0,00 0,00 0,00
Total liabilities 1 253 770,61 1 001 588,12 3 008 054,55 9 069 456,00 5 460 835,71 3 514 350,68
A. Equity -1 300 397,93 -3 593 319,42 2 422 928,77 7 260 652,03 4 138 844,69 2 557 632,52
B. Liabilities and provisions for liabilities 2 554 168,54 4 594 907,54 585 125,78 1 808 803,97 1 321 991,02 956 718,16
I. Long-term liabilities 0,00 833 840,47 0,00 0,00 0,00 0,00
II. Short-term liabilities 2 376 670,22 3 289 556,22 196 785,22 1 698 492,31 1 158 573,09 746 733,81
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.